VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome

Journal of Alzheimer's Disease

Volumn 21, Issue 1, 2010, Pages 87-94

  Borroni, Barbara ^a   Del Bo, Roberto ^b   Goldwurm, Stefano ^c   Archetti, Silvana ^a   Bonvicini, Cristian ^d   Agosti, Chiara ^a   Bigni, Barbara ^a   Papetti, Alice ^a   Ghezzi, Serena ^b   Sacilotto, Giorgio ^c   Pezzoli, Gianni ^c   Gennarelli, Massimo ^a,d   Bresolin, Nereo ^b   Comi, Giacomo Pietro ^b   Padovani, Alessandro ^a,e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c PARKINSON INSTITUTE   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e Ente Universitario Lombardia Orientale   (Italy)

Author keywords

Corticobasal syndrome; frontotemporal dementia; haplotype; polymorphism; progressive supranuclear palsy; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

AGED; ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC CORRELATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SINGLE NUCLEOTIDE POLYMORPHISM; BASAL GANGLIA DISEASES; BLOOD; CHI SQUARE DISTRIBUTION; FRONTOTEMPORAL DEMENTIA; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NONPARAMETRIC TEST; PROCEDURES; RISK FACTOR; SUPRANUCLEAR PALSY, PROGRESSIVE;

AGED; BASAL GANGLIA DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STATISTICS, NONPARAMETRIC; SUPRANUCLEAR PALSY, PROGRESSIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955000583     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091615     Document Type: Article

References (26)

1. Lang AE (1994) Cortical-basal ganglionic degeneration. Neurodegenerative Disease, Philadelphia: Saunders: Calne DB. eds., pp. 877-894.
2. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 47, 1-9.
3. Joseph KA (2008) Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol 115, 39-53.
4. Kertesz A, Hillis A, Munoz D (2003) Frontotemporal degeneration, Pick's Disease, Pick Complex and Ravel. Ann Neurol 54 S5, S1-S2.
5. Ros R, Thobois S, Streichenberger N, Kopp N, Sanchez MP, Perez M, Hoenicka J, Avila J, Honnorat J, de Yebenes JG (2005) A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy. Arch Neurol 62,1444-1450.
6. Masellis M, Momeni P, Meschino W, Heffner R Jr, Elder J, Sato C, Liang Y, St George-Hyslop P, Hardy J, Bilbao J, Black S, Rogaeva E (2006) Novel splicing mutation in the progranulin gene causing familial corticobasal degeneration syndrome. Brain 129, 3115-3123.
7. Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC (2009) Familial aggregation of parkinsonism in progressive supra nuclear palsy. Neurology 73, 98-105.
8. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. HumMol Genet 8, 711-715. (Pubitemid 29139987)
9. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bha-tia KP, Dickson D, Wood NW, Hutton M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702-1706. (Pubitemid 32574570)
10. Webb A, Miller B, Bonasera S, Boxer A, Karydas A, Wil-helmsen KC (2008) Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders. Arch Neurol 65, 1473-1478.
11. Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25, 561-570.
12. Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R (2006) Haplotype-specific expression of exon 10 at the human MAPT locus. HumMol Genet 15, 3529-3537.
13. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corn-eveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hut-ton M, Stephan DA (2007) Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet 80, 769-778.
14. Borroni B, Ghezzi S, Agosti C, Archetti S, Fenoglio C, Galim-berti D, Scarpini E, Di Luca M, Bresolin N, Comi GP, Padovani A, Del Bo R (2008) Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration. Rejuvenation Res 11, 773-780.
15. Rosenstein JM, Krum JM (2004) New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187, 246253.
16. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8, 85-92.
17. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ; Work Group on Frontotemporal Dementia and Pick's Disease (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58, 1803-1809.
18. Barrett HH, Wilson DW, Tsui BM (1994) Noise properties of the EM algorithm: I. Theory. Phys Med Biol 39, 833-846.
19. Williams DR, Pittman AM, Revesz T, Lees AJ, de Silva R (2007) Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy. Mov Disord 22, 895-897.
20. Pastor P, Ezquerra M, Perez JC, Chakraverty S, Norton J, Racette BA, McKeel D, Perlmutter JS, Tolosa E, Goate AM. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Ann Neurol 56, 249-528.
21. Carmeliet P, Storkebaum E (2002) Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin CellDevBiol 13, 39-53.
22. De Almodovar CR, Lambrechts D, Mazzone M, Carmeliet P (2009) Role and therapeutic potentials of VEGF in the nervous system. Physion Rev 89, 607-648.
23. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular en-dothelial growth factor gene promoter. Cancer Res 63, 812-816.
24. Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP, Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GPF. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57, 373-380.
25. Chiappelli M, Borroni B, Archetti S, Calabrese E, Corsi MM, Franceschi M, Padovani A, Licastro F (2006) VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res 9, 485-493.
26. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beck-man L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34, 383-389.